Organometallic complexes offer potential for design as anticancer drugs. They can act as
inert scaffolds and specifically inhibit enzymes such as kinases, or as pro-drugs which …

Upconverting nanoparticles for the near infrared photoactivation of transition metal complexes:
new opportunities and challenges in medicinal inorgani ... - Dalton Transactions (RSC …

Although Ru (II)-based agents are expected to be promising candidates for substituting Pt-
drug, their in vivo biomedical applications are still limited by the short excitation/emission …

Organometallic complexes containing ligands such as CO, carbenes, alkyls, phenyls, π-
bound alkynes, alkenes, cyclopentadienyls and arenes possess properties which have often …

Bioorganometallic chemistry is a rapidly developing area of research. In recent years
organometallic compounds have provided a rich platform for the design of effective catalysts …

A new anticancer agent based on the conjugation of a photoactivatable Pt (IV) pro-drug to a
cyclic RGD-containing peptide is described. Upon visible light irradiation, phototoxicity was …

Six complexes of formula [Ir (η5: κ1-C5Me4CH2py)(C, N)] PF6, where C5Me4CH2py is 2-((2,
3, 4, 5-tetramethylcyclopentadienyl) methyl) pyridine, and C, N is 2-phenylpyridine (1), 7, 8 …

Ruthenium (Ru) complexes are known for their promising anticancer activity presumably
due to octahedral coordination geometry, slow ligand exchange rate, the range of different …

Photoactivated chemotherapy (PACT) is a novel cancer treatment method that has drawn
increasing attention due to its high selectivity and low side effects by spatio-temporal control …

Background: Cancer chemotherapy is limited by severe side effects due to unspecific
cytotoxic activity of currently used therapeutics. In order to minimize these unwanted effects …